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Background: Comparisons among countries in the management of consecutive patients with acute non ST segment elevation myocardial 
infarction (NSTEMI) are lacking.
methods: We compared the use of in-hospital procedures and discharge medications for patients with NSTEMI from 2007 to 2010 using the 
MINAP/NICOR (UK; n=137,009), SWEDEHEART/RIKS-HIA (Sweden; n=45,069), and ACTION Registry-GWTG (US; n=148,194) clinical registries.
results: The US registry had a higher proportion of PCI-capable hospitals. Patients in the UK and Sweden registries were older but less likely to 
have comorbid conditions. Angiography and PCI were performed less often and beta-blockers at discharge were prescribed less often in the UK 
compared with Sweden and the US. However, prescription of dual antiplatelet agents, statins, and ACEI/ARB were highest in the UK. Over the four 
years, the performance of PCI increased most in the UK but remained lower than in the other two countries. Dual antiplatelet and ACEI/ARB use 
increased in Sweden, and beta-blocker use increased in the UK. Use of other medication was relatively stable. (Table)
conclusion: Differences exist in the acute management of patients after NSTEMI among hospitals in these registries in the UK, Sweden, and the 
US. Gaps in care are narrowing in some practices but not in others. Understanding these differences may identify areas for improvement as well as 
provide insight for future investigations into outcomes.
